Accueil
Détail d'une collection
|
Documents disponibles dans la collection (28)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Rapport
Europol ; L. LANIEL ; C. CARPENTIER ; J. MOUNTENEY ; B. PALLAVICINI ; L. ROYUELA ; J. MATIAS ; R. KASECKER ; R. SEDEFOV ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Joint publications | 2011FRANÇAIS : L'OEDT et Europol publient une analyse conjointe concernant le marché des amphétamines. Leader dans la production des amphétamines, l'Europe est également une zone importante de consommation. ENGLISH: This joint publication with [...]Rapport
OEDT = EMCDDA ; CCSA (Canadian Centre on Substance Use and Addiction) (Ottawa, ON) | Lisbon : OEDT / EMCDDA | Joint publications | 2018FRANÇAIS : Avec l'usage de cannabis et les politiques le concernant en constante évolution dans le monde entier, la drogue au volant est devenue un enjeu politique de taille. Le présent document s'adresse aux responsables de l'élaboration de po[...]Rapport
Europol ; L. LANIEL ; C. CARPENTIER ; C. COSTA STORTI ; A. GALLEGOS ; D. LOPEZ ; C. MARTEL ; L. ROYUELA ; R. SEDEFOV ; R. SIMON ; J. WRIGHT ; F. ZOBEL ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Joint publications | 2010This report provides an overview of what is known about how cocaine is produced and trafficked into the European Union. It aims to provide a better understanding of the actors involved, the routes taken, and the scale of the problem in Europe. I[...]Rapport
OEDT = EMCDDA ; Inter-American Drug Abuse Control Commission of American States (CICAD-OAS) | Lisbon : OEDT / EMCDDA | Joint publications | 2010National drugs observatories have flourished and developed rapidly over the last two decades as a direct consequence of the decisions taken to establish regional drug monitoring systems, both in the European Union and in the Americas. Initially[...]Rapport
This report presents a summary of the key findings from drug treatment facility surveys carried out in 2017 in Albania, Bosnia and Herzegovina, Serbia and the territory of Kosovo. The results provide insight into the characteristics and capacity[...]Rapport
This joint report prepared by the EMCDDA and Europol considers the latest findings from international research, fresh empirical data, and operational information and intelligence in order to illuminate how darknet markets function and how they r[...]Congrès
Commission européenne = European Commission, Organisateur de réunion ; P. KENIS ; Drugs: Research related initiatives in the European Union (13 and 14 December 1996; The Robert Schuman centre, European University Institute, Florence) | Lisbon : OEDT / EMCDDA | Joint publications | 1997In 1996, representatives of the 15 Member States and individual researchers were invited to a joint seminar, organised by the European Commission and the EMCDDA, entitled 'Drug research-related initiatives in the European Union'. The seminar was[...]Rapport
European Centre for Disease Prevention and Control ; OEDT = EMCDDA | Lisbon : OEDT / EMCDDA | Joint publications | 2011FRANÇAIS : Sept interventions, un objectif : zéro infections parmi les personnes qui s’injectent des drogues. Dans un nouveau rapport d'orientation publié aujourd'hui, deux agences de l'UE, l'ECDC et l'OEDT, ont uni leurs efforts pour recenser [...]Rapport
In May 2015, the EMCDDA and Europol examined the available information on a new psychoactive substance 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone, commonly known as alpha-pyrrolidinovalerophenone (alpha-PVP), through a joint assessment. The two org[...]Rapport
FRANÇAIS : L'usage de tabac et d'alcool chez les élèves de 15 à 16 ans donne des signes de déclin, mais la consommation potentiellement problématique de cannabis et les difficultés posées par les nouvelles conduites addictives soulèvent des in[...]Rapport
What effect is COVID-19 having on the drug market in the EU? This joint publication from the EMCDDA and Europol analyses the impact of the pandemic on the market for the main drug types (cannabis, heroin, cocaine, amphetamines, NPS), including d[...]Rapport
The EU Drug Markets Report 2019 is the third comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol. The analysis presented in this report spans numerous topics such as the links between drugs and other cr[...]Rapport
FRANÇAIS : Le présent rapport analyse le phénomène du marché des drogues illicites dans le contexte plus large des nouvelles tendances en matière de consommation de drogue, des facteurs culturels et sociaux et des liens avec la criminalité. Les[...]Rapport
The EU drug markets report is the first comprehensive overview of illicit drug markets in the European Union. It covers issues such as production, consumer markets, trafficking, organised crime and policy responses, along with a review of the ma[...]Rapport
OEDT = EMCDDA ; European Centre for Disease Prevention and Control | Lisbon : OEDT / EMCDDA | Joint publications | 2012ENGLISH: In response to a notified increase in HIV cases among injecting drug users (IDU) in Greece and Romania, the European Commission asked the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for [...]Rapport
This report provides a summary of the key findings from the assessment of progress of the EU Member States, Norway and Turkey towards the implementation of the revised drug supply indicators, as developed by the EMCDDA in line with the Council c[...]Rapport
This publication is the first in a series dedicated to prevalent illicit synthetic stimulant drugs, also known as amphetamine-type stimulants (ATS). The ATS category is made up of two groups of substances. This study focuses on the supply and us[...]Rapport
This report provides a comprehensive overview of the methamphetamine market in the European Union. It assesses the current threat situation regarding current trends in production, trafficking and distribution.Rapport
The European new psychoactive substances (NPS) market has increased at a speed that established drug control laws struggle to match. Various countries have therefore introduced new legal responses to this phenomenon, based either on existing law[...]Rapport
A. L. BRETTEVILLE-JENSEN ; C. COSTA STORTI ; T. KATTAU ; S. MIKULIC ; F. TRIGUEIROS ; F. PAPAMALIS ; L. PISCOCIU ; S. TSAREV | Lisbon : OEDT / EMCDDA | Joint publications | 2017Evaluating drug policy is an integral part of a cost-efficient approach to tackle illicit drugs. This report takes a first step towards a systematic analysis, by examining a set of representative attempts to estimate public expenditure on supply[...]Rapport
OEDT = EMCDDA ; European Centre for Disease Prevention and Control | Lisbon : OEDT / EMCDDA | Joint publications | 2018What are the most (cost-) effective ways to prevent and control communicable diseases in prison settings? In their joint public health Guidance, ECDC and the EMCDDA, present the evidence on active case finding as a key measure to diagnose commun[...]Rapport
OEDT = EMCDDA ; European Centre for Disease Prevention and Control | Lisbon : OEDT / EMCDDA | Joint publications | 2018This evidence-based guidance aims to support the planning and implementation of effective programmes to prevent and control the transmission of infectious diseases in prison settings in the European region. It focuses on three high-burden blood-[...]Rapport
OEDT = EMCDDA ; European Centre for Disease Prevention and Control | Lisbon : OEDT / EMCDDA | Joint publications | 2017A higher prevalence of communicable diseases among people in prison compared with the general public is recognised as a public health issue as well as a major concern for the people affected, as the majority of incarcerated people return to thei[...]Rapport
OEDT = EMCDDA ; European Centre for Disease Prevention and Control | Lisbon : OEDT / EMCDDA | Joint publications | 2018Compared with the general public, people in prisons have a higher prevalence of infection with blood-borne viruses (BBVs) such as human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV). This is recognised as a ma[...]Rapport
After the launch of the 2011 ESPAD report, a second impact survey (similar to the first one from 2003) was conducted in 2012 to explore whether interest in, use of and impact of the ESPAD 2011 report was as high as that found after the 1995 and [...]